Chlorophyll-Based supplement may ease radiation damage in cervical cancer patients

NCT ID NCT07164534

Not yet recruiting Symptom relief Sponsor: Tata Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether a daily dose of sodium-copper-chlorophyllin, a chlorophyll derivative, can reduce long-term bladder and bowel side effects from radiation therapy in 316 women with locally advanced cervical cancer. Participants take the supplement for 3 months after completing standard chemoradiation. The study compares side effects at 24 months between those taking the supplement and those receiving standard follow-up care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sodium-copper-chlorophyllin
What this could lead to: If it works, this could offer a simple, short-term supplement to reduce long-term bladder and bowel damage after cervical cancer radiation, improving quality of life.
What could go wrong: This is a phase 3 trial, but it's not yet recruiting. The supplement may not reduce side effects as hoped, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED ADENOCARCINOMA OF THE CERVIX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical adenocarcinoma cervical cancer cervical squamous cell carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UTERINE CERVICAL NEOPLASM

More trials for these conditions

Other studies related to the condition(s) this trial covers.